Longboard Pharmaceuticals Price on May 23, 2024

LBPHDelisted Stock  USD 59.98  0.00  0.00%   
If you're considering investing in Longboard Stock, it is important to understand the factors that can impact its price. As of today, the current price of Longboard Pharmaceuticals stands at 59.98, as last reported on the 10th of January, with the highest price reaching 59.98 and the lowest price hitting 59.98 during the day. Longboard Pharmaceuticals is very steady at the moment. Longboard Pharmaceuticals has Sharpe Ratio of 0.27, which conveys that the firm had a 0.27% return per unit of risk over the last 3 months. We have found twenty-five technical indicators for Longboard Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Longboard Pharmaceuticals' Risk Adjusted Performance of 0.1156, mean deviation of 3.24, and Downside Deviation of 4.01 to check out if the risk estimate we provide is consistent with the expected return of 0.0451%.
  
Longboard Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.2745

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsLBPH

Estimated Market Risk

 0.16
  actual daily
1
99% of assets are more volatile

Expected Return

 0.05
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.27
  actual daily
21
79% of assets perform better
Based on monthly moving average Longboard Pharmaceuticals is performing at about 21% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Longboard Pharmaceuticals by adding it to a well-diversified portfolio.

Related Headline

Werewolf Therapeutics Headline on 23rd of May 2024

- Updated single agent dose escalation data continues to demonstrate that WTX-124 is well tolerated and clinically active in patients with checkpoint inhibitor therapy relapsedrefractory cancers - - Preliminary data on WTX-124 administered in combination with pembrolizumab show similar tolerability to WTX-124 monotherapy - - Additional details and data post abstract cut-off date to be presented at ASCO - - Company to host webcast to review these data on Monday, June 3, 2024, at 800 am ET - WAT

Longboard Pharmaceuticals Valuation on May 23, 2024

It is possible to determine the worth of Longboard Pharmaceuticals on a given historical date. On May 23, 2024 Longboard was worth 19.73 at the beginning of the trading date compared to the closed value of 18.94. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Longboard Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Longboard Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Longboard Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Longboard Pharmaceuticals' related companies.
 Open High Low Close Volume
  20.72    21.28    19.66    19.73    243,271  
05/23/2024
  19.73    19.93    18.57    18.94    250,374  
  19.35    19.35    18.41    18.80    167,002  
Backtest Longboard Pharmaceuticals  |  Longboard Pharmaceuticals History  |  Longboard Pharmaceuticals Valuation   PreviousNext  
Open Value
19.73
18.94
Closing Value
20.22
Upside

Longboard Pharmaceuticals Trading Date Momentum on May 23, 2024

On May 24 2024 Longboard Pharmaceuticals was traded for  18.80  at the closing time. The top price for the day was 19.35  and the lowest listed price was  18.41 . The trading volume for the day was 167 K. The trading history from May 24, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.74% . The trading delta at closing time against the current closing price is 1.37% .

Longboard Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Longboard Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Longboard Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Longboard financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Longboard Pharmaceuticals Stock history

Longboard Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Longboard is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Longboard Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Longboard Pharmaceuticals stock prices may prove useful in developing a viable investing in Longboard Pharmaceuticals
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California. Longboard Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 21 people.

Longboard Pharmaceuticals Stock Technical Analysis

Longboard Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Longboard Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Longboard Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Longboard Pharmaceuticals Period Price Range

Low
January 10, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Longboard Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Longboard Pharmaceuticals January 10, 2025 Market Strength

Market strength indicators help investors to evaluate how Longboard Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Longboard Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Longboard Pharmaceuticals stock market strength indicators, traders can identify Longboard Pharmaceuticals entry and exit signals to maximize returns

Longboard Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Longboard Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Longboard Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Longboard to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Longboard Stock

If you are still planning to invest in Longboard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Longboard Pharmaceuticals' history and understand the potential risks before investing.
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Valuation
Check real value of public entities based on technical and fundamental data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stocks Directory
Find actively traded stocks across global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world